MedTrace Logo

Dexmedetomidine in Topical Versus Peribulbar Anesthesia for Cataract Surgery

NCT05692167 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2023-09-07

No results posted yet for this study

Summary

The aim of this study is to compare efficacy of dexmedetomidine as an additive to topical versus peribulbar anesthesia for cataract surgery

Conditions

  • Dexmedetomidine
  • Cataract Surgery
  • Peribulbar
  • Anesthesia

Interventions

DRUG

Topical dexmedetomidine

Patients will receive mixture of one milliliter of dexmedetomidine-HCl and local anesthetic

DRUG

Reginal dexmedetomidine

Patients will receive mixture of bupivacaine 0.5% (4.5 ml) + lidocaine 2% (4.5 ml) + dexmedetomidine 50 μg (1 ml) in peribulbar block

Sponsors & Collaborators

  • Kafrelsheikh University

    lead OTHER

Principal Investigators

  • Mohammed F Algyar, MD · Lecturer of Anaesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Kafrelsheikh University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-15
Primary Completion
2023-10-15
Completion
2023-10-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05692167 on ClinicalTrials.gov